Combining drug-disease and economic modelling to inform drug development decisions

被引:27
|
作者
Poland, B [1 ]
Wada, R [1 ]
机构
[1] Pharsight Corp, Mt View, CA 94040 USA
关键词
D O I
10.1016/S1359-6446(01)02014-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug-disease models and clinical trial simulations are increasingly being used to support trial design and treatment optimization decisions. Less widely recognized is their potential for guiding strategic development decisions. These decisions require economic valuation of the potential product profile of efficacy, safety, ease of use, and so on. This review presents a disguised case study that uses drug-disease modelling to generate a probabilistic forecast of a drug's profile. This allows a quantitative analysis of whether to pursue a once-a-day regimen for an antiretroviral being tested twice-a-day in Phase II trials, and if so, at what dose and for which market segments.
引用
收藏
页码:1165 / 1170
页数:6
相关论文
共 50 条
  • [1] A Comprehensive Review of Novel Drug-Disease Models in Diabetes Drug Development
    Gaitonde, Puneet
    Garhyan, Parag
    Link, Catharina
    Chien, Jenny Y.
    Trame, Mirjam N.
    Schmidt, Stephan
    CLINICAL PHARMACOKINETICS, 2016, 55 (07) : 769 - 788
  • [2] The Use of Economic Evidence to Inform Drug Pricing Decisions in Jordan
    Hammad, Eman A.
    VALUE IN HEALTH, 2016, 19 (02) : 233 - 238
  • [3] Predicting drug-disease associations and their therapeutic function based on the drug-disease association bipartite network
    Zhang, Wen
    Yue, Xiang
    Huang, Feng
    Liu, Ruoqi
    Chen, Yanlin
    Ruan, Chunyang
    METHODS, 2018, 145 : 51 - 59
  • [4] Exploiting drug-disease relationships for computational drug repositioning
    Dudley, Joel T.
    Deshpande, Tarangini
    Butte, Atul J.
    BRIEFINGS IN BIOINFORMATICS, 2011, 12 (04) : 303 - 311
  • [5] DRUG-DRUG AND DRUG-DISEASE INTERACTIONS WITH NONSTEROIDAL ANTIINFLAMMATORY DRUGS
    JEFFERSON, JW
    GREIST, JH
    CARROLL, J
    BAUDHUIN, M
    AMERICAN JOURNAL OF MEDICINE, 1986, 81 (05): : 948 - 948
  • [6] DRUG-DRUG AND DRUG-DISEASE INTERACTIONS WITH NONSTEROIDAL ANTIINFLAMMATORY DRUGS
    BRATER, DC
    AMERICAN JOURNAL OF MEDICINE, 1986, 80 (1A): : 62 - 77
  • [7] Identification of Drug-Disease Associations by Using Multiple Drug and Disease Networks
    Yang, Ying
    Chen, Lei
    CURRENT BIOINFORMATICS, 2022, 17 (01) : 48 - 59
  • [8] Inferring drug-disease associations by a deep analysis on drug and disease networks
    Chen, Lei
    Chen, Kaiyu
    Zhou, Bo
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2023, 20 (08) : 14136 - 14157
  • [9] The Evaluation and Use of Economic Evidence to Inform Cancer Drug Reimbursement Decisions in Canada
    Jean H. E. Yong
    Jaclyn Beca
    Jeffrey S. Hoch
    PharmacoEconomics, 2013, 31 : 229 - 236
  • [10] The Evaluation and Use of Economic Evidence to Inform Cancer Drug Reimbursement Decisions in Canada
    Yong, Jean H. E.
    Beca, Jaclyn
    Hoch, Jeffrey S.
    PHARMACOECONOMICS, 2013, 31 (03) : 229 - 236